Literature DB >> 26339058

Phenotypic Correlates of HIV-1 Macrophage Tropism.

Kathryn T Arrildt1, Celia C LaBranche2, Sarah B Joseph1, Elena N Dukhovlinova3, William D Graham3, Li-Hua Ping3, Gretja Schnell4, Christa B Sturdevant1, Laura P Kincer3, Macpherson Mallewa5, Robert S Heyderman6, Annelies Van Rie7, Myron S Cohen8, Serena Spudich9, Richard W Price10, David C Montefiori2, Ronald Swanstrom11.   

Abstract

UNLABELLED: HIV-1 is typically CCR5 using (R5) and T cell tropic (T-tropic), targeting memory CD4(+) T cells throughout acute and chronic infections. However, viruses can expand into alternative cells types. Macrophage-tropic (M-tropic) HIV-1 variants have evolved to infect macrophages, which have only low levels of surface CD4. Most M-tropic variants have been isolated from the central nervous system during late-stage chronic infection. We used the HIV-1 env genes of well-defined, subject-matched M-tropic and T-tropic viruses to characterize the phenotypic features of the M-tropic Env protein. We found that, compared to T-tropic viruses, M-tropic viruses infect monocyte-derived macrophages (MDMs) on average 28-fold more efficiently, use low-density CD4 more efficiently, have increased sensitivity to soluble CD4 (sCD4), and show trends toward sensitivity to some CD4 binding site antibodies but no difference in sensitivity to antibodies targeting the CD4-bound conformation. M-tropic viruses also displayed a trend toward resistance to neutralization by monoclonal antibodies targeting the V1/V2 region of Env, suggesting subtle changes in Env protein conformation. The paired M- and T-tropic viruses did not differ in autologous serum neutralization, temperature sensitivity, entry kinetics, intrinsic infectivity, or Env protein incorporation. We also examined viruses with modestly increased CD4 usage. These variants have significant sensitivity to sCD4 and may represent evolutionary intermediates. CD4 usage is strongly correlated with infectivity of MDMs over a wide range of CD4 entry phenotypes. These data suggest that emergence of M-tropic HIV-1 includes multiple steps in which a phenotype of increased sensitivity to sCD4 and enhanced CD4 usage accompany subtle changes in Env conformation. IMPORTANCE: HIV-1 typically replicates in CD4(+) T cells. However, HIV-1 can evolve to infect macrophages, especially within the brain. Understanding how CCR5-using macrophage-tropic viruses evolve and differ from CCR5-using T cell-tropic viruses may provide insights into viral evolution and pathogenesis within the central nervous system. We characterized the HIV-1 env viral entry gene from subject-matched macrophage-tropic and T cell-tropic viruses to identify entry features of macrophage-tropic viruses. We observed several differences between T cell-tropic and macrophage-tropic Env proteins, including functional differences with host CD4 receptor engagement and possible changes in the CD4 binding site and V1/V2 region. We also identified viruses with phenotypes between that of "true" macrophage-tropic and T cell-tropic viruses, which may represent evolutionary intermediates in a multistep process to macrophage tropism.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26339058      PMCID: PMC4645658          DOI: 10.1128/JVI.00946-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  107 in total

1.  Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa.

Authors:  Ming Li; Jesus F Salazar-Gonzalez; Cynthia A Derdeyn; Lynn Morris; Carolyn Williamson; James E Robinson; Julie M Decker; Yingying Li; Maria G Salazar; Victoria R Polonis; Koleka Mlisana; Salim Abdool Karim; Kunxue Hong; Kelli M Greene; Miroslawa Bilska; Jintao Zhou; Susan Allen; Elwyn Chomba; Joseph Mulenga; Cheswa Vwalika; Feng Gao; Ming Zhang; Bette T M Korber; Eric Hunter; Beatrice H Hahn; David C Montefiori
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

2.  Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.

Authors:  E S Gray; P L Moore; I A Choge; J M Decker; F Bibollet-Ruche; H Li; N Leseka; F Treurnicht; K Mlisana; G M Shaw; S S Abdool Karim; C Williamson; L Morris
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

3.  Dynamics of simian immunodeficiency virus populations in blood and cerebrospinal fluid over the full course of infection.

Authors:  Patrick R Harrington; Mary J Connell; Rick B Meeker; Philip R Johnson; Ronald Swanstrom
Journal:  J Infect Dis       Date:  2007-08-29       Impact factor: 5.226

4.  Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop.

Authors:  Maria José Duenas-Decamp; Paul Peters; Dennis Burton; Paul R Clapham
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

5.  Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia.

Authors:  Rebecca L Dunfee; Elaine R Thomas; Jianbin Wang; Kevin Kunstman; Steven M Wolinsky; Dana Gabuzda
Journal:  Virology       Date:  2007-06-27       Impact factor: 3.616

6.  Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.

Authors:  David C Montefiori
Journal:  Curr Protoc Immunol       Date:  2005-01

7.  Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.

Authors:  Wei Huang; Susan H Eshleman; Jonathan Toma; Signe Fransen; Eric Stawiski; Ellen E Paxinos; Jeannette M Whitcomb; Alicia M Young; Deborah Donnell; Francis Mmiro; Philippa Musoke; Laura A Guay; J Brooks Jackson; Neil T Parkin; Christos J Petropoulos
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

8.  Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.

Authors:  Elaine R Thomas; Rebecca L Dunfee; Jennifer Stanton; Derek Bogdan; Joann Taylor; Kevin Kunstman; Jeanne E Bell; Steven M Wolinsky; Dana Gabuzda
Journal:  Virology       Date:  2006-11-07       Impact factor: 3.616

9.  Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.

Authors:  Paul J Peters; Maria J Duenas-Decamp; W Matthew Sullivan; Richard Brown; Chiambah Ankghuambom; Katherine Luzuriaga; James Robinson; Dennis R Burton; Jeanne Bell; Peter Simmonds; Jonathan Ball; Paul R Clapham
Journal:  Retrovirology       Date:  2008-01-18       Impact factor: 4.602

10.  Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.

Authors:  Jasminka Sterjovski; Melissa J Churchill; Anne Ellett; Lachlan R Gray; Michael J Roche; Rebecca L Dunfee; Damian F J Purcell; Nitin Saksena; Bin Wang; Secondo Sonza; Steven L Wesselingh; Ingrid Karlsson; Eva-Maria Fenyo; Dana Gabuzda; Anthony L Cunningham; Paul R Gorry
Journal:  Retrovirology       Date:  2007-12-12       Impact factor: 4.602

View more
  28 in total

1.  Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.

Authors:  Sarah B Joseph; Laura P Kincer; Natalie M Bowman; Chris Evans; Michael J Vinikoor; Christopher K Lippincott; Magnus Gisslén; Serena Spudich; Prema Menezes; Kevin Robertson; Nancie Archin; Angela Kashuba; Joseph J Eron; Richard W Price; Ronald Swanstrom
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

Review 2.  HIV-associated neurocognitive disorder.

Authors:  David B Clifford
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

Review 3.  Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections.

Authors:  Sarah R DiNapoli; Vanessa M Hirsch; Jason M Brenchley
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

4.  HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.

Authors:  Olubusuyi Moses Adewumi; Elena Dukhovlinova; Nathan Y Shehu; Shuntai Zhou; Olivia D Council; Maxwell O Akanbi; Babafemi Taiwo; Adesola Ogunniyi; Kevin Robertson; Cecilia Kanyama; Mina C Hosseinipour; Ronald Swanstrom
Journal:  AIDS Res Hum Retroviruses       Date:  2020-02-17       Impact factor: 2.205

5.  Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications.

Authors:  Maria Paz Gonzalez-Perez; Paul J Peters; Olivia O'Connell; Nilsa Silva; Carole Harbison; Sheila Cummings Macri; Saravanan Kaliyaperumal; Katherine Luzuriaga; Paul R Clapham
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

Review 6.  Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.

Authors:  Teresa H Evering
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

Review 7.  Macrophages and HIV-1: An Unhealthy Constellation.

Authors:  Quentin J Sattentau; Mario Stevenson
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

Review 8.  Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses.

Authors:  Lot D de Witte; Monique Nijhuis; Stephanie B H Gumbs; Raphael Kübler; Lavina Gharu; Pauline J Schipper; Anne L Borst; Gijsje J L J Snijders; Paul R Ormel; Amber Berdenis van Berlekom; Annemarie M J Wensing
Journal:  J Neurovirol       Date:  2022-02-09       Impact factor: 3.739

9.  Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1.

Authors:  Jason E Hammonds; Neal Beeman; Lingmei Ding; Sarah Takushi; Ashwanth C Francis; Jaang-Jiun Wang; Gregory B Melikyan; Paul Spearman
Journal:  PLoS Pathog       Date:  2017-01-27       Impact factor: 6.823

Review 10.  HIV evolution and diversity in ART-treated patients.

Authors:  Gert van Zyl; Michael J Bale; Mary F Kearney
Journal:  Retrovirology       Date:  2018-01-30       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.